Healthcare provider profile · identity verified

Terez Metry, MD

Internal Medicine · DAYTON, OH · NPI 1265487250

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	588	172
Levothyroxine Sodium	Levothyroxine Sodium	505	130
Amlodipine Besylate	Amlodipine Besylate	460	132
Omeprazole	Omeprazole	347	83
Gabapentin	Gabapentin	294	72
Lisinopril	Lisinopril	288	91
Simvastatin	Simvastatin	262	75
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	245	68
Metoprolol Succinate	Metoprolol Succinate	231	52
Pantoprazole Sodium	Pantoprazole Sodium	220	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	209	40
Metformin Hcl	Metformin Hcl	199	62
Furosemide	Furosemide	193	55
Rosuvastatin Calcium	Rosuvastatin Calcium	191	55
Sertraline Hcl	Sertraline Hcl	173	31
Glimepiride	Glimepiride	170	44
Duloxetine Hcl	Duloxetine Hcl	169	36
Metoprolol Tartrate	Metoprolol Tartrate	169	54
Montelukast Sodium	Montelukast Sodium	166	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	157	43
Hydrochlorothiazide	Hydrochlorothiazide	147	44
Losartan Potassium	Losartan Potassium	139	38
Meloxicam	Meloxicam	128	39
Carvedilol	Carvedilol	120	35
Alprazolam	Alprazolam	116	21
Potassium Chloride	Potassium Chloride	115	32
Buspirone Hcl	Buspirone Hcl	111	25
Albuterol Sulfate Hfa	Albuterol Sulfate	110	36
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	107	29
Lorazepam	Lorazepam	104	20
Valsartan	Valsartan	104	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	15
Clopidogrel	Clopidogrel Bisulfate	96	34
Pregabalin	Pregabalin	96	33
Eliquis	Apixaban	90	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	35
Allopurinol	Allopurinol	84	25
Pravastatin Sodium	Pravastatin Sodium	83	26
Trazodone Hcl	Trazodone Hcl	82	27
Ozempic	Semaglutide	80	13
Tamsulosin Hcl	Tamsulosin Hcl	80	23
Methocarbamol	Methocarbamol	79	30
Synthroid	Levothyroxine Sodium	77	27
Escitalopram Oxalate	Escitalopram Oxalate	75	18
Glipizide	Glipizide	74	14
Atenolol	Atenolol	73	16
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	72	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	71	18
Tizanidine Hcl	Tizanidine Hcl	66	15
Hydralazine Hcl	Hydralazine Hcl	65	20
Famotidine	Famotidine	64	15
Donepezil Hcl	Donepezil Hcl	63	11
Ibuprofen	Ibuprofen	63	24
Citalopram Hbr	Citalopram Hydrobromide	60	16
Oxybutynin Chloride Er	Oxybutynin Chloride	60	suppressed
Topiramate	Topiramate	60	12
Tramadol Hcl	Tramadol Hcl	58	14
Trulicity	Dulaglutide	58	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	57	16
Esomeprazole Magnesium	Esomeprazole Magnesium	56	14
Mirtazapine	Mirtazapine	54	suppressed
Azithromycin	Azithromycin	52	44
Fluticasone Propionate	Fluticasone Propionate	51	20
Metformin Hcl Er	Metformin Hcl	50	13
Spironolactone	Spironolactone	47	12
Fluoxetine Hcl	Fluoxetine Hcl	46	12
Meclizine Hcl	Meclizine Hcl	44	19
Nifedipine Er	Nifedipine	43	suppressed
Prednisone	Prednisone	42	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	11
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	12
Terazosin Hcl	Terazosin Hcl	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	31
Naproxen	Naproxen	38	17
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Divalproex Sodium Er	Divalproex Sodium	37	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	36	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Mounjaro	Tirzepatide	35	suppressed
Ondansetron Odt	Ondansetron	35	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	12
Arnuity Ellipta	Fluticasone Furoate	34	12
Celecoxib	Celecoxib	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	13
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Clonazepam	Clonazepam	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Acyclovir	Acyclovir	28	11
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Amoxicillin	Amoxicillin	27	20
Paxlovid	Nirmatrelvir/Ritonavir	27	26
Fluconazole	Fluconazole	26	19
Verapamil Er	Verapamil Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	13
Ibu	Ibuprofen	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Testosterone	Testosterone	23	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	14
Cephalexin	Cephalexin	20	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Estradiol	Estradiol	18	suppressed
Klor-Con M10	Potassium Chloride	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Finasteride	Finasteride	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Cabergoline	Cabergoline	12	suppressed
Clonidine	Clonidine	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Hydrocortisone Valerate	Hydrocortisone Valerate	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Norvasc	Amlodipine Besylate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error